Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: A systematic review and meta-analysis.
De Rocco S, Buca D, Oronzii L, Petrillo M, Fanfani F, Nappi L, Liberati M, D'Antonio F, Scambia G, Leombroni M, Dessole M, Lucidi A.
Can a higher endometrial thickness threshold exclude endometrial cancer and atypical hyperplasia in asymptomatic postmenopausal women? A systematic review.
Li JXL, Chan F, Johansson CYM.
Aust N Z J Obstet Gynaecol. 2022 Apr;62(2):190-197. doi: 10.1111/ajo.13472. Epub 2022 Jan 7.
PMID:34994399
Current research of Assisted Reproductive Technology for women with early endometrial cancer and atypical endometrial hyperplasia after conservative treatment.
Jiang YL, Lin YY, Chen CX, Li YX, Xie HY, Zheng BH.
Front Endocrinol (Lausanne). 2024 Jun 11;15:1377396. doi: 10.3389/fendo.2024.1377396. eCollection 2024.